Depressed youth, suicidality and antidepressants

Joseph M Rey and Michael J Dudley
Med J Aust 2005; 182 (8): . || doi: 10.5694/j.1326-5377.2005.tb06754.x
Published online: 18 April 2005

No cause for panic, but an incentive to improve clinical practice

The use of selective serotonin reuptake inhibitors (SSRIs) in depressed children and adolescents has received consider-able attention in the past year; this attention has included concerns about increased suicide risk, revised evidence about effectiveness, growing prescription numbers, and revelations of drug companies withholding data.1 The discovery of unforeseen risks in other drugs such as cyclooxygenase-2 inhibitors has intensified the climate of uncertainty and mistrust about drug treatment. Some argue that to diagnose major depression in children is to medicalise the unhappiness caused by affluence, permissiveness, a decaying family and society.2 By contrast, medical practitioners and governments have been told during the last quarter century that depression is a serious illness that can lead to suicide, poor physical health, and personal, professional and social difficulties. Thus, the Australian community has invested considerable resources in trying to tackle this scourge (eg, The National Depression Initiative3). If experts disagree, it is little wonder that the public and clinicians are confused, yet severely depressed teenagers continue to come to doctors for management.

  • Joseph M Rey1
  • Michael J Dudley2

  • 1 Department of Psychological Medicine, University of Sydney, North Ryde, NSW.
  • 2 School of Psychiatry, University of New South Wales, Randwick, NSW.


Competing interests:

Professor Rey was a member of the advisory committee for Strattera (Eli Lilly) and Concerta (Janssen-Cilag) and was funded by Eli Lilly to attend an international conference. No agency or other source has funded or influenced the design or content of this article. Dr Dudley has often attended dinners sponsored by Pfizer, and received gifts from various drug companies (bags, CDs, pens etc). This has not influenced the content of this article.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.